• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALYDIA HEALTH JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALYDIA HEALTH JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Model Number JADA-1001
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 06/07/2021
Event Type  Injury  
Manufacturer Narrative
In this use of jada, care was escalated for the original diagnosis of postpartum hemorrhage, consistent with the device labeling.The user facility did not allege that the device caused or contributed to patient injury or escalation of care.It is unclear based on the information provided if the jada malfunctioned or if it functioned as expected but the bleeding continued due to other factors.Out of an abundance of caution, we are reporting this event due to the 30-day reporting deadline.If we become aware of additional information, we will supplement this report.The submission of this report is not an admission that the device caused or contributed to the reported event.
 
Event Description
It was reported that the patient was scheduled for induction of labor and underwent an emergency c-section for non-reassuring fetal heart tones.After the skin was closed, 500cc of blood and clots were expressed.The patient was examined and the uterus was found to be atonic.She was given a dose of hemabate and decision was made to use the jada device to control the bleeding.The jada device was inserted without complications, and set to a pressure of 90mmhg.The patient continued to have profuse bleeding from the uterus and started to have hypotension.She was given a dose of methergine, another dose of hemabate, misoprostol and txa.At this point, the decision to begin transfusion, with o negative blood until cross matched blood arrived to the unit.The massive transfusion protocol was initiated.Given the profuse amount of bleeding even with the jada device and multiple uterotonics, the decision was made to re-op.The skin was opened, followed by the subcutaneous tissue and fascia.Upon entry there was minimal amount of intraperitoneal blood.The hysterotomy was inspected and found to be hemostatic.In addition, the uterus appeared to be well contracted from above and the level of the fundus.A decision was then made to reassess from below.The lower uterine segment continued to be atonic, however was responding better to uterotonic agents.A bakri balloon was placed and filled to 350cc, which helped control and stop the bleeding from the uterus.The cervix was also inspected and a cervical laceration was ruled out.The patient was then noted to have a 2cm left sulcal laceration, likely from the time of insertion of bakri balloon given her narrow pubic arch and pelvis.The sulcal laceration was repaired.Floseal was applied to the area and 3 vaginal packs were placed.She received a total of 8uprbc, 6uffp, 1plt, 1cryo.She remained intubated due to difficulty oxygenating likely secondary to pulmonary edema.She was transferred to the sicu in stable condition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ALYDIA HEALTH
3495 edison way
menlo park CA 94025
Manufacturer (Section G)
ALYDIA HEALTH
3495 edison way
menlo park CA 94025
Manufacturer Contact
richard ferrick
3495 edison way
menlo park, CA 94025
8445232666
MDR Report Key12451601
MDR Text Key270785689
Report Number3017425145-2021-00019
Device Sequence Number1
Product Code OQY
UDI-Device Identifier00850017882003
UDI-Public(01)00850017882003
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/09/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberJADA-1001
Device Catalogue NumberJADA-1001
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/10/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
1 UNIT CYROPRECIPITATE; 1 UNIT PLATELETS; 6 UNITS FRESH FROZEN PLASMA; 6 UNITS PRBC; BAKRI; HEMABATE; METHERGINE; MISOPROSTOL; TXA
Patient Outcome(s) Required Intervention;
Patient Age44 YR
Patient Weight67
-
-